US · Healthcare

Phyto Extractions Inc (XTXXF)

Drug Manufacturers - Specialty & Generic

Phyto Extractions Inc (XTXXF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for XTXXF

P/E ratio

18.00

Phyto Extractions Inc (XTXXF) — FAQ

What is XTXXF's P/E ratio?

The price-to-earnings (P/E) ratio for Phyto Extractions Inc (XTXXF) is 18.00 (data as of 2026-05-23).

Does Phyto Extractions Inc pay a dividend?

Dividend yield is not available in the current snapshot for Phyto Extractions Inc (XTXXF). Check the MyAverix Finance app for the latest dividend data.

What sector is Phyto Extractions Inc in?

Phyto Extractions Inc (XTXXF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is XTXXF listed on?

XTXXF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)